Search our Available Technologies
By Clinical Application > Infectious Diseases
Structural analogues of 3- [(2,6-difluorobenzoyl)amino]-5-(4-ethoxyphenyl)thiophene-2-carboxylic acid as lead compounds for preventing or treating urinary tract infections
Value Proposition Uropathogenic Escherichia coli (UPEC) is the leading cause...
MORE >Structural analogues of N-pyridin-4-yl-1,3-benzothiazole-6-carboxamide as lead compounds for preventing or treating urinary tract infections
Value Proposition Uropathogenic Escherichia coli (UPEC) is the leading cause...
MORE >A therapeutic vaccine platform for treating influenza viruses
Value Proposition Influenza virus infections represent a substantial global burden...
MORE >Small molecules that can safely exploit copper as an antimicrobial
Value Proposition The fungal pathogen Cryptococcus neoformans can live in...
MORE >A new class of antifungal compounds
Value Proposition The standard of care available to patients suffering...
MORE >Intubation tent to protect healthcare workers from infected patients
Value Proposition Under the current COVID crisis, health care workers...
MORE >Compositions and methods for treating gram-negative bacterial infection
Value Proposition Antimicrobial resistance is considered to be one of...
MORE >Device for personalizing ventilation settings on a shared system
Value Proposition In times of emergency, multiple patients might require...
MORE >Antibodies for the detection of Ebola virus infection
Value Proposition Ebola Virus Disease (EVD) is a severe, often...
MORE >Novel small molecule mast cell activator vaccine adjuvants
Value Proposition Mast cells (MCs) are innate immune cells highly...
MORE >